Bilirubin derived from heme degradation suppresses MHC class II expression in endothelial cells
- 16 December 2005
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 338 (2), 890-896
- https://doi.org/10.1016/j.bbrc.2005.10.021
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antioxidant Activities of Bile PigmentsAntioxidants and Redox Signaling, 2004
- Biliverdin, a natural product of heme catabolism, induces tolerance to cardiac allograftsThe FASEB Journal, 2004
- Bilirubin rinse: A simple protectant against the rat liver graft injury mimicking heme oxygenase-1 preconditioningHepatology, 2003
- Prevention of Chronic Deterioration of Heart Allograft by Recombinant Adeno-Associated Virus-Mediated Heme Oxygenase-1 Gene TransferCirculation, 2003
- Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in miceNature Medicine, 2002
- Transfer of Heme Oxygenase 1 cDNA by a Replication-Deficient Adenovirus Enhances Interleukin 10 Production from Alveolar Macrophages That Attenuates Lipopolysaccharide-Induced Acute Lung Injury in MiceHuman Gene Therapy, 2001
- Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injuryJCI Insight, 1999
- Expression of heme oxygenase-1 can determine cardiac xenograft survivalNature Medicine, 1998
- Lymphokine dependence of in vivo expression of MHC class II antigens by endotheliumNature, 1985
- Role of MHC Gene Products in Immune RegulationScience, 1981